Precision medicine in myocardial infarction: Nanotheranostic strategies
Abstract Myocardial infarction (MI) is the most prevalent non‐communicable disease worldwide. Nanotheranostics have made significant progress in the biomedical field, presenting an avenue to overcome the limitations of conventional approaches towards MI, in which personalized interventions have enha...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2024-03-01
|
| Series: | Nano Select |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/nano.202300127 |
| _version_ | 1797267977587916800 |
|---|---|
| author | Alexander Shao‐Rong Pang Vishalli Dinesh Natalie Yan‐Lin Pang Tarini Dinesh Kimberley Yun‐Lin Pang George W. Yip Boon Huat Bay Dinesh Kumar Srinivasan |
| author_facet | Alexander Shao‐Rong Pang Vishalli Dinesh Natalie Yan‐Lin Pang Tarini Dinesh Kimberley Yun‐Lin Pang George W. Yip Boon Huat Bay Dinesh Kumar Srinivasan |
| author_sort | Alexander Shao‐Rong Pang |
| collection | DOAJ |
| description | Abstract Myocardial infarction (MI) is the most prevalent non‐communicable disease worldwide. Nanotheranostics have made significant progress in the biomedical field, presenting an avenue to overcome the limitations of conventional approaches towards MI, in which personalized interventions have enhanced nanotherapeutic efficacy. The pharmacokinetics and pharmacodynamics of nanoscale materials have been modified through alteration of their physical and chemical properties such as structure, size, and surface, thereby improving target sensitivity and specificity. This revolutionary technology has also been accomplished through precision therapeutics in MI. In this review, we discuss advanced nanoparticle designs utilized in the diagnosis and treatment of MI that could be applied to deliver personalized treatment and improve patient outcomes. |
| first_indexed | 2024-04-25T01:25:09Z |
| format | Article |
| id | doaj.art-d27630dd5306437dab485faa7525433f |
| institution | Directory Open Access Journal |
| issn | 2688-4011 |
| language | English |
| last_indexed | 2024-04-25T01:25:09Z |
| publishDate | 2024-03-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Nano Select |
| spelling | doaj.art-d27630dd5306437dab485faa7525433f2024-03-09T03:15:04ZengWiley-VCHNano Select2688-40112024-03-0153n/an/a10.1002/nano.202300127Precision medicine in myocardial infarction: Nanotheranostic strategiesAlexander Shao‐Rong Pang0Vishalli Dinesh1Natalie Yan‐Lin Pang2Tarini Dinesh3Kimberley Yun‐Lin Pang4George W. Yip5Boon Huat Bay6Dinesh Kumar Srinivasan7Yong Loo Lin School of Medicine National University of Singapore Singapore SingaporeDepartment of Pathology Dhanalakshmi Srinivasan Medical College Hospital Perambalur Tamil Nadu IndiaYong Loo Lin School of Medicine National University of Singapore Singapore SingaporeDepartment of Medicine Government Kilpauk Medical College Chennai Tamil Nadu IndiaCollege of Medicine and Public Health Flinders University Adelaide South Australia AustraliaDepartment of Anatomy Yong Loo Lin School of Medicine National University of Singapore Singapore SingaporeDepartment of Anatomy Yong Loo Lin School of Medicine National University of Singapore Singapore SingaporeDepartment of Anatomy Yong Loo Lin School of Medicine National University of Singapore Singapore SingaporeAbstract Myocardial infarction (MI) is the most prevalent non‐communicable disease worldwide. Nanotheranostics have made significant progress in the biomedical field, presenting an avenue to overcome the limitations of conventional approaches towards MI, in which personalized interventions have enhanced nanotherapeutic efficacy. The pharmacokinetics and pharmacodynamics of nanoscale materials have been modified through alteration of their physical and chemical properties such as structure, size, and surface, thereby improving target sensitivity and specificity. This revolutionary technology has also been accomplished through precision therapeutics in MI. In this review, we discuss advanced nanoparticle designs utilized in the diagnosis and treatment of MI that could be applied to deliver personalized treatment and improve patient outcomes.https://doi.org/10.1002/nano.202300127drug delivery systemsmyocardial infarctnanodiagnosticsnanoparticlesprecision therapy |
| spellingShingle | Alexander Shao‐Rong Pang Vishalli Dinesh Natalie Yan‐Lin Pang Tarini Dinesh Kimberley Yun‐Lin Pang George W. Yip Boon Huat Bay Dinesh Kumar Srinivasan Precision medicine in myocardial infarction: Nanotheranostic strategies Nano Select drug delivery systems myocardial infarct nanodiagnostics nanoparticles precision therapy |
| title | Precision medicine in myocardial infarction: Nanotheranostic strategies |
| title_full | Precision medicine in myocardial infarction: Nanotheranostic strategies |
| title_fullStr | Precision medicine in myocardial infarction: Nanotheranostic strategies |
| title_full_unstemmed | Precision medicine in myocardial infarction: Nanotheranostic strategies |
| title_short | Precision medicine in myocardial infarction: Nanotheranostic strategies |
| title_sort | precision medicine in myocardial infarction nanotheranostic strategies |
| topic | drug delivery systems myocardial infarct nanodiagnostics nanoparticles precision therapy |
| url | https://doi.org/10.1002/nano.202300127 |
| work_keys_str_mv | AT alexandershaorongpang precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT vishallidinesh precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT natalieyanlinpang precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT tarinidinesh precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT kimberleyyunlinpang precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT georgewyip precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT boonhuatbay precisionmedicineinmyocardialinfarctionnanotheranosticstrategies AT dineshkumarsrinivasan precisionmedicineinmyocardialinfarctionnanotheranosticstrategies |